Pine Pharmaceuticals, LLC

The FDA's record of Pine Pharmaceuticals, LLC of Tonawanda, NY, a registered 503B outsourcing facility: its registration dates and its inspection record.

Checked against the FDA registered outsourcing facilities list on Oct 25, 2026. See the list on fda.gov

503B outsourcing facilityLast inspection Nov 14, 2025

Pine Pharmaceuticals, LLC of Tonawanda, New York is on the FDA’s list of facilities registered as human drug compounding outsourcing facilities under section 503B of the Federal Food, Drug, and Cosmetic Act. The FDA says the list includes the facilities whose registration information it has determined to be complete.1

The list dates its last inspection Nov 14, 2025. The FDA dates an inspection by the day it issued a Form FDA 483, or, where it issued none, by the last day of the inspection.1

Action based on the last inspection, as the list states it: “Warning Letter Issued 8/7/2026”.1

The record

What the FDA register shows

ColumnWhat the register showsSource
FacilityPine Pharmaceuticals, LLC, Tonawanda, NYFDA register
Initial registration dateMar 9, 2018FDA register
Most recent registration dateOct 9, 2026FDA register
Last inspectionNov 14, 2025FDA register
Form 483 issued?Yes: read the Form 483 on fda.govFDA register
Recall conducted?NoFDA register
Action based on last inspectionWarning Letter Issued 8/7/2026FDA register
Intends to compound sterile drugs from bulk substancesYesStated by the facility at registration; not verified by the FDA

A Form FDA 483 lists conditions an FDA investigator observed during an inspection that in their judgment may be violations. The FDA says it is not a final agency determination of whether any condition is a violation.2

How a 503B outsourcing facility differs from a 503A pharmacy: 503A vs 503B.

This page restates public FDA records as they stood on the check date above. It is not legal or medical advice.

Related pages
Data sources
  1. 1.
    FDA registered outsourcing facilitiesU.S. Food and Drug Administrationretrieved Oct 25, 2026↩
  2. 2.
    FDA Form 483 frequently asked questionsU.S. Food and Drug Administration↩
  3. 3.
    Form FDA 483 issued to Pine Pharmaceuticals, LLCU.S. Food and Drug Administration